Skip to content

Can Alternative Treatment Have an Impact on Cervical Dysplasia?

Can Mindfulness Meditation Limit the Progression and/or Increase the Remission of Cervical Dysplasia?

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842738
Enrollment
200
Registered
2009-02-12
Start date
2009-03-31
Completion date
2011-12-31
Last updated
2010-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dysplasia

Keywords

Screening, Cervical cancer, Cervical dysplasia, Adverse psychosocial effects, Alternative treatment

Brief summary

In this study two questions will be answered: * can mindfulness meditation help cell-changed on the cervix to disappear? * can mindfulness meditation lower the psychological distress when women have abnormal cervical cancer screening results?

Detailed description

200 women, who have participated in cervical cancer screening and have mild dysplasia, will be randomized into two groups; an intervention group and a control group. The intervention group will be asked to do mindfulness meditation twice a week listening to instructions from a CD. 200 additional women having normal cervical screening results will also be included in the project.

Interventions

BEHAVIORALMindfulness meditation

Mindfulness meditation

Health care services as usual

OTHERControls

No intervention

Sponsors

Danish Cancer Society
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
23 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Women aged 23-29 years * Participated in cervical cancer screening * Having mild dysplasia and normal screening results

Exclusion criteria

* Women who have previously had dysplasia

Design outcomes

Primary

MeasureTime frame
The degree of cervical dysplasia6 months after screening

Secondary

MeasureTime frame
Psychosocial consequences measured with the COS-CC questionnaire1 week, 3 and 9 months after screening

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026